- Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
- Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
- Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 14, 2024
- Eton Pharmaceuticals Awarded U.S. Patent for Proprietary Hydrocortisone Oral Liquid Formulation
- Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules
- Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results
- Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
- Eton Pharmaceuticals Announces Acquisition of FDA-Approved Ultra-Rare Disease Product Nitisinone
- Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
More ▼
Key statistics
As of last trade, Eton Pharmaceuticals Inc (ETON:NMQ) traded at 3.71, 53.31% above the 52 week low of 2.42 set on Jul 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.81 |
---|---|
High | 3.88 |
Low | 3.70 |
Bid | 3.71 |
Offer | 3.76 |
Previous close | 3.80 |
Average volume | 110.90k |
---|---|
Shares outstanding | 25.69m |
Free float | 22.36m |
P/E (TTM) | -- |
Market cap | 97.61m USD |
EPS (TTM) | -0.0389 USD |
Data delayed at least 15 minutes, as of Mar 28 2024 18:18 BST.
More ▼